Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?

Koom, Woong Sub; Seong, Jinsil; Han, Kwang Hyub; Lee, Do Yun; Lee, Jong Tae
International journal of radiation oncology, biology, physics
2010Aug ; 77 ( 5 ) :1433-40.
ÀúÀÚ »ó¼¼Á¤º¸
Koom, Woong Sub -
Seong, Jinsil -
Han, Kwang Hyub -
Lee, Do Yun -
Lee, Jong Tae -
ABSTRACT
PURPOSE: To investigate whether local radiotherapy (RT) is valuable for patients with multiple hepatocellular carcinomas (HCCs). METHODS AND MATERIALS: From July 1992 to August 2006, 107 patients with unresectable HCC were treated with local RT after incomplete transcatheter arterial chemoembolization (TACE). The RT field included a main tumor with or without other tumor nodules, depending on the effectiveness of TACE. The median RT dose was 50.4 Gy in conventional fractionation. Patients were categorized into four groups: Group 1, single tumor (39 patients); Group 2, multiple tumors within the RT field (25 patients); Group 3, controlled tumors out of the RT field (19 patients); and Group 4, tumors that remained viable out of the RT field (24 patients).

RESULTS: Group 1 showed the best survival rate (MST, 35 months; 2-year OS, 60%) and Group 4 the worst (MST, 5 months; 2-year OS, 16%). Group 2 and Group 3 showed similar survival (MST, 13 vs. 19 months; 2-year OS, 35% vs. 46%; p = 0.698). Significantly worse intrahepatic control in Group 4 was observed. The survival in Groups 2 and 3 (MST, 16 months) was significantly different from that in Group 4 (p = 0.004), and was marginally significant compared with that in Group 1 (p = 0.051).

CONCLUSIONS: Local RT to the main tumor could be applicable in well-controlled intrahepatic tumors out of the RT field. Patients with viable intrahepatic tumors out of the RT field showed worse survival. In future clinical trials, these patients need to be excluded. CI - Copyright 2010 Elsevier Inc. All rights reserved.
na
MESH
Adult, Aged, Analysis of Variance, Carcinoma, Hepatocellular/drug, Chemoembolization, Therapeutic/methods, Combined Modality Therapy/methods, Female, Humans, Infusions, Intra-Arterial/methods, Liver Neoplasms/drug therapy/mortality/pathology/*radiotherapy, Male, Middle Aged, Neoplasms, Multiple Primary/drug therapy/*mortality/pathology/*radiotherapy, Radiotherapy Dosage, Remission Induction, Survival Rate, Tumor Burden
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Application of local RT after unsatisfactory TACE could be considered an option for treatment of multiple intrahepatic tumors, particularly in patients with multiple tumors that are covered by the same RT field.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1016/j.ijrobp.2009.07.1676
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå